Sabra Health Care REIT, Inc. has entered into a new equity distribution agreement with a consortium of financial institutions, including major players such as Barclays Capital Inc., BMO Capital Markets Corp., and Morgan Stanley & Co. LLC. This agreement, established on August 5, 2025, allows for the sale of shares of the company's common stock, with proceeds intended for repaying debts, funding future investments, and general corporate purposes. The sales will be managed by the consortium, with an aggregate compensation for agents potentially reaching up to $11.25 million. The company also terminated a prior distribution agreement from February 2023 that allowed for up to $500 million in stock sales.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.